Hussain R, Lim C, Shaukat Z, Islam A, Caseley E, Lippiat J
Sci Rep. 2024; 14(1):3357.
PMID: 38336906
PMC: 10858247.
DOI: 10.1038/s41598-024-53588-x.
Liu R, Sun L, Wang Y, Wang Q, Wu J
Neurol Sci. 2022; 44(4):1201-1206.
PMID: 36437393
DOI: 10.1007/s10072-022-06521-x.
Ferretti A, Simeoli R, Cairoli S, Pietrafusa N, Trivisano M, Vici C
Pharmaceutics. 2022; 14(10).
PMID: 36297665
PMC: 9608568.
DOI: 10.3390/pharmaceutics14102230.
Burbano L, Li M, Jancovski N, Jafar-Nejad P, Richards K, Sedo A
JCI Insight. 2022; 7(23).
PMID: 36173683
PMC: 9746904.
DOI: 10.1172/jci.insight.146090.
Knowles J, Helbig I, Metcalf C, Lubbers L, Isom L, Demarest S
Epilepsia. 2022; 63(10):2461-2475.
PMID: 35716052
PMC: 9561034.
DOI: 10.1111/epi.17332.
A Review of Targeted Therapies for Monogenic Epilepsy Syndromes.
Zimmern V, Minassian B, Korff C
Front Neurol. 2022; 13:829116.
PMID: 35250833
PMC: 8891748.
DOI: 10.3389/fneur.2022.829116.
Electrophysiological Biomarkers in Genetic Epilepsies.
Armstrong C, Marsh E
Neurotherapeutics. 2021; 18(3):1458-1467.
PMID: 34642905
PMC: 8609056.
DOI: 10.1007/s13311-021-01132-4.
Rational Small Molecule Treatment for Genetic Epilepsies.
Goldberg E
Neurotherapeutics. 2021; 18(3):1490-1499.
PMID: 34431030
PMC: 8609069.
DOI: 10.1007/s13311-021-01110-w.
Case Report of Novel Genetic Variant in KCNT1 Channel and Pharmacological Treatment With Quinidine. Precision Medicine in Refractory Epilepsy.
Kravetz M, Viola M, Prenz J, Curi M, Bramuglia G, Tenembaum S
Front Pharmacol. 2021; 12:648519.
PMID: 34122071
PMC: 8194824.
DOI: 10.3389/fphar.2021.648519.
Reduced GABAergic Neuron Excitability, Altered Synaptic Connectivity, and Seizures in a KCNT1 Gain-of-Function Mouse Model of Childhood Epilepsy.
Shore A, Colombo S, Tobin W, Petri S, Cullen E, Dominguez S
Cell Rep. 2020; 33(4):108303.
PMID: 33113364
PMC: 7712469.
DOI: 10.1016/j.celrep.2020.108303.
Precision medicine and therapies of the future.
Sisodiya S
Epilepsia. 2020; 62 Suppl 2:S90-S105.
PMID: 32776321
PMC: 8432144.
DOI: 10.1111/epi.16539.
Structure-Based Identification and Characterization of Inhibitors of the Epilepsy-Associated K1.1 (KCNT1) Potassium Channel.
Cole B, Johnson R, Dejakaisaya H, Pilati N, Fishwick C, Muench S
iScience. 2020; 23(5):101100.
PMID: 32408169
PMC: 7225746.
DOI: 10.1016/j.isci.2020.101100.
Therapy in Sleep-Related Hypermotor Epilepsy (SHE).
Asioli G, Rossi S, Bisulli F, Licchetta L, Tinuper P, Provini F
Curr Treat Options Neurol. 2020; 22(1):1.
PMID: 31997091
DOI: 10.1007/s11940-020-0610-1.
eHealth as a Facilitator of Precision Medicine in Epilepsy.
Cavalleri G, Petrovski S, Fitzsimons M, Delanty N
Biomed Hub. 2020; 2(Suppl 1):137-145.
PMID: 31988944
PMC: 6945901.
DOI: 10.1159/000481793.
Epilepsy with migrating focal seizures: KCNT1 mutation hotspots and phenotype variability.
Barcia G, Chemaly N, Kuchenbuch M, Eisermann M, Gobin-Limballe S, Ciorna V
Neurol Genet. 2019; 5(6):e363.
PMID: 31872048
PMC: 6878841.
DOI: 10.1212/NXG.0000000000000363.
Concurrent Quinidine and Phenobarbital in the Treatment of a Patient with 2 Mutations.
Passey C, Erramouspe J, Castellanos P, ODonnell E, Denton D
Curr Ther Res Clin Exp. 2019; 90:106-108.
PMID: 31388363
PMC: 6677567.
DOI: 10.1016/j.curtheres.2019.02.002.
Two South Indian Children with KCNT1-Related Malignant Migrating Focal Seizures of Infancy - Clinical Characteristics and Outcome of Targeted Treatment with Quinidine.
Patil A, Vinayan K, Roy A
Ann Indian Acad Neurol. 2019; 22(3):311-315.
PMID: 31359944
PMC: 6613401.
DOI: 10.4103/aian.AIAN_229_18.
Treatment Responsiveness in KCNT1-Related Epilepsy.
Fitzgerald M, Fiannacca M, Smith D, Gertler T, Gunning B, Syrbe S
Neurotherapeutics. 2019; 16(3):848-857.
PMID: 31054119
PMC: 6694367.
DOI: 10.1007/s13311-019-00739-y.
Quinidine Therapy for Lennox-Gastaut Syndrome With Mutation. A Case Report and Literature Review.
Jia Y, Lin Y, Li J, Li M, Zhang Y, Hou Y
Front Neurol. 2019; 10:64.
PMID: 30804880
PMC: 6370615.
DOI: 10.3389/fneur.2019.00064.
The Fever Tree: from Malaria to Neurological Diseases.
Eyal S
Toxins (Basel). 2018; 10(12).
PMID: 30477182
PMC: 6316520.
DOI: 10.3390/toxins10120491.
